Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | NOX1 | Q9Y5S8 | 5/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | S100B | P04271 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7044213 | 0.93 | SNCA (0.41) | SNCAALDH1A1MAPTTDP1GAA | |
| SCHEMBL1470932 | 0.92 | SNCA (0.40) | SNCAALDH1A1MAPTTDP1GAA | |
| Iodide SCHEMBL3711622 | 0.91 | NOX1 (0.55) | SNCAALDH1A1MAPTTDP1GAA | |
| Iodide SCHEMBL3711621 | 0.91 | NOX1 (0.55) | SNCAALDH1A1MAPTTDP1GAA | |
| Iodide SCHEMBL3711619 | 0.91 | NOX1 (0.55) | SNCAALDH1A1MAPTTDP1GAA | |
| Bromide SCHEMBL3712204 | 0.86 | SNCA (0.38) | SNCAALDH1A1MAPTTDP1GAA | |
| Bromide SCHEMBL3715669 | 0.86 | SNCA (0.38) | SNCAALDH1A1MAPTTDP1GAA | |
| SCHEMBL12592413 | 0.86 | SNCA (0.43) | SNCAALDH1A1MAPTTDP1GAA | |
| SCHEMBL11763092 | 0.85 | TSHR (0.54) | ALDH1A1MAPTTDP1GAALMNA | |
| SCHEMBL2429634 | 0.84 | S100B (0.41) | SNCAALDH1A1MAPTTDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1591267-B1 | Materials for imaging | HEWLETT PACKARD DEVELOPMENT CO (US) | 2007-12-05 | — | — | EP | claimed |
| US-7169542-B2 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-01-30 | — | — | US | claimed |
| US-20060275693-A9 | COMPOSITIONS, SYSTEMS, AND METHODS FOR IMAGING | KASPERCHIK VLADEK | 2006-12-07 | — | — | US | claimed |
| EP-1591267-A2 | Compositions, systems, and methods for imaging | Hewlett-Packard Development Company, L.P. (US) | 2005-11-02 | — | — | EP | claimed |
| US-20050100817-A1 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, LP | 2005-05-12 | — | — | US | claimed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2025-06-10 | — | — | US | disclosed |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2024-07-25 | — | — | US | disclosed |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2024-04-09 | — | — | US | disclosed |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2022-05-31 | — | — | US | disclosed |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2022-05-31 | — | — | US | disclosed |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2022-05-19 | — | — | US | disclosed |
| US-20050100817-A1 | Compositions, systems, and methods for imaging | HEWLETT-PACKARD DEVELOPMENT COMPANY, LP | 2005-05-12 | — | — | US | disclosed |
| US-20050037281-A1 | Light-sensitive sheet comprising support, first and second light-sensitive layers and barrier layer | FUJI PHOTO FILM CO., LTD. | 2005-02-17 | — | — | US | disclosed |
| EP-1507171-A2 | Light-Sensitive sheet comprising support, first and second light-sensitive layers and barrier layer | FUJI PHOTO FILM CO., LTD. (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-20050025946-A1 | Light-sensitive sheet comprising support, first light-sensitive layer and second light-sensitive layer | FUJI PHOTO FILM CO., LTD. | 2005-02-03 | — | — | US | disclosed |
| EP-1489460-A2 | Light-sensitive sheet comprising support, first light-sensitive layer and second light-sensitive layer | Fuji Photo Film Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-5756356-A | COLORIMETRIC | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0735368-A1 | Method of indicating time or temperature-time accumulated value as color change, and materials therefor | TOYO INK MANUFACTURING CO., LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
| US-3974041-A | Image recording member with zeolitic water containing compounds | CANON KABUSHIKI KAISHA (JA) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 673/4885ALDH1A1 2648/4885MAPT 9/4885 |
| US-12324810-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 467/4885ALDH1A1 2818/4885MAPT 11/4885 |
| US-11951110-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 673/4885ALDH1A1 2648/4885MAPT 9/4885 |
| US-11344558-B2 | 3, 7-diamino-10H-phenothiazine salts and their use | PSEN1, PSEN2, APP | SNCA 673/4885ALDH1A1 2648/4885MAPT 9/4885 |
| US-20220152038-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 437/4885ALDH1A1 1821/4885MAPT 15/4885 |
| US-20240245700-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 467/4885ALDH1A1 2818/4885MAPT 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.